The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2019
Filed:
Sep. 19, 2015
Applicant:
The University of Tokyo, Tokyo, JP;
Inventors:
Chieko Kai, Tokyo, JP;
Misako Yoneda, Tokyo, JP;
Assignee:
THE UNIVERSITY OF TOKYO, Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/165 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01); C12N 15/09 (2006.01); A61K 35/768 (2015.01);
U.S. Cl.
CPC ...
A61K 39/165 (2013.01); A61K 35/768 (2013.01); C12N 7/00 (2013.01); C12N 15/09 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/54 (2013.01); A61K 2039/552 (2013.01); A61K 2039/572 (2013.01); A61K 2039/585 (2013.01); C12N 2760/18421 (2013.01); C12N 2760/18422 (2013.01); C12N 2760/18433 (2013.01); C12N 2760/18434 (2013.01); C12N 2760/18471 (2013.01);
Abstract
It is an object of the present invention to provide a medicament or a pharmaceutical composition, which is effective for the treatment of various cancers. More specifically, the present invention relates to a pharmaceutical composition for use in the treatment of cancers, which comprises rMV-SLAM-blind or rMV-V(−)-SLAM-blind. The pharmaceutical composition has the effect of causing the regression of tumor, even if it is intravenously administered, and it also exhibits effects on cancer metastasized from a primary lesion.